Dimainvest Targets Shedir Pharma Delisting with Acquisition Offer

Shedir Pharma Group S.P.A. (IT:SHE) has released an update.

Dimainvest S.r.l. has announced a voluntary public acquisition offer for the remaining 11.92% of Shedir Pharma Group S.p.A.’s ordinary shares, aiming to delist the company from Euronext Growth Milan. The offer values each share at Euro 4.90, totaling approximately Euro 6.68 million for the shares subject to the offer.

For further insights into IT:SHE stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.